Aster Labs unveils Digital Pathology Solution approved by USFDA
Aster Labs has introduced US FDA approved digital pathology solution at two of its facilities.
The diagnostics arm of Aster DM Healthcare, a healthcare service...
Piramal Pharma Solutions on expansion mode, invests ~$32 Million
Piramal Pharma Solutions, a Piramal Pharma Limited business and a leading Contract Development and Manufacturing Organization (CDMO), has revealed its plans to expand its...
Sandoz ships first medicine in partnership with Civica Rx to United States hospitals
Sandoz Inc said it has pantoprazole sodium for injection, 40 mg to Civica Rx to supply hospitals in the United States it serves. This...
Shocking info: Dangers of deterenol revealed
Shocking it may sound, but researchers have urged consumers to avoid using weight loss or sports supplements that list deterenol as an ingredient.
Scientists at...
Biohaven gives important update on phase 2/3 trial and Alzheimer’s disease program
Biohaven Pharmaceutical Holding Company Ltd has announced completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical...
GSK and Medicago commence Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Medicago and GSK have announced the beginning of Phase 2/3 clinical trials of plant-derived vaccine candidate for Covid-19.
The study is being done to assess...
AstraZeneca starts Phase 2b clinical study of medicine to lower cholesterol: Ionis
Ionis Pharmaceuticals, Inc. has said that the AstraZeneca has commenced a Phase 2b clinical trial of ION449 (AZD8233).
It is an investigational antisense medicine designed...
Sputnik V vaccine’s efficacy confirmed at 91.4%
Sputnik V, the Russian Covid-19 vaccine, has passed a crucial test. Its efficacy has been confirmed at 91.4 per cent bsed on data analysis...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...
Matrix Medical Network ties up with AstraZeneca
Matrix Medical Network has announced a partnership with AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting monoclonal antibody (LAAB)...
